Y Intercept Hong Kong Ltd Takes $5.02 Million Position in Oscar Health, Inc. $OSCR

Y Intercept Hong Kong Ltd acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 234,153 shares of the company’s stock, valued at approximately $5,020,000.

Other institutional investors and hedge funds have also modified their holdings of the company. LRI Investments LLC increased its position in shares of Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock valued at $26,000 after purchasing an additional 975 shares during the period. Jones Financial Companies Lllp increased its position in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio acquired a new stake in Oscar Health in the 1st quarter valued at $30,000. Larson Financial Group LLC boosted its stake in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after buying an additional 2,512 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in Oscar Health by 71.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,658 shares of the company’s stock valued at $57,000 after buying an additional 1,107 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the transaction, the insider owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 25.11% of the company’s stock.

Analyst Upgrades and Downgrades

OSCR has been the topic of several recent analyst reports. Robert W. Baird reaffirmed a “neutral” rating and issued a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. The Goldman Sachs Group initiated coverage on Oscar Health in a research note on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target on the stock. UBS Group reaffirmed a “sell” rating and issued a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Finally, Baird R W lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Six investment analysts have rated the stock with a Hold rating and six have assigned a Sell rating to the company. According to MarketBeat.com, Oscar Health has a consensus rating of “Reduce” and a consensus price target of $13.19.

Oscar Health Price Performance

Oscar Health stock opened at $19.58 on Wednesday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The firm has a market cap of $5.06 billion, a P/E ratio of -24.17 and a beta of 1.89. The business’s fifty day moving average is $18.99 and its two-hundred day moving average is $16.51. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm’s quarterly revenue was up 29.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.20 earnings per share. Equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.